Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-20

FDA Approved: MORPHINE SULFATE EXTENDED RELEASE — Supplemental Application (Rhodes Pharmaceuticals L. P.)

View source ↗

Summary

FDA approved a supplemental application for Morphine Sulfate Extended Release submitted by Rhodes Pharmaceuticals L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE)